TMCnet News

Cardiovascular Systems Board Chair to Retire [Global Data Point]
[September 18, 2014]

Cardiovascular Systems Board Chair to Retire [Global Data Point]


(Global Data Point Via Acquire Media NewsEdge) Scott R. Ward, a CSI director since 2013, will be named chairman. Ward is a managing director at SightLine Partners, LLC. He has over 30 years of experience in Medical Technology and spent nearly two decades in executive leadership positions at Medtronic, including president of its cardiovascular business. Additionally, Ward is the chairman of Creganna-Tactx Medical and Surmodics, Inc. He also serves on the board of ImpediMed, Ltd. and numerous private medical technology companies.



Said Ward, "On behalf of CSI, our stockholders and the physicians whom we serve, we thank Dr. Nelson for his extraordinary leadership and his dedication to improving the quality of care for patients with peripheral and coronary vascular disease. During his tenure, the company evolved from a pre-revenue organization to an annualized run rate in excess of $150 million in revenue with a growing portfolio of vascular devices. The successful growth of CSI reflects Dr. Nelson's passion for medical technology, sound judgment and steady guidance." Dr. Nelson said, "It has been an honor to serve as a CSI board member and chair. I'm very proud of CSI's continued dedication to developing and commercializing technologies that effectively treat a very sick patient population. I leave the chairmanship with CSI on solid ground for future growth. Scott Ward is an accomplished medical technology executive and business leader. He will be a tremendous asset to CSI as the company continues to build its commercial product line, capabilities and international presence. I look forward to participating in CSI's future success as chairman emeritus and as a significant shareholder." (c) 2014 GlobalData Provided by SyndiGate Media Inc. (Syndigate.info).

[ Back To TMCnet.com's Homepage ]